Please login to the form below

Not currently logged in
Email:
Password:

Pfizer gives evidence for closure of plant

Pfizer is to give evidence to the UK's Science and Technology Committee over the closure of its Kent plant

Pfizer is to give evidence to the UK's Science and Technology Committee over the closure of its Kent research and development facility.

The pharmaceutical company will discuss its reasons for shutting down the facility, which is to take place over the next two years with the loss of 2,400 jobs.

It is the Science and Technology Committee's role to regulate and examine the activities of the Government Office for Science, a semi-autonomous organisation within the Department for Business, Innovation and Skills (BIS).

Pfizer employees giving evidence to the Committee include Dr Olivier Brandicourt, president and general manager of Pfizer's Primary Care Business Unit; Dr Rod MacKenzie, senior vice president and head of worldwide research for PharmaTherapeutics Research and Development; Dr Ruth McKernan, senior vice president and site head, Sandwich, and chief scientific officer for Pfizer Regenerative Medicine; and Richard Blackburn, managing director, Pfizer UK.

Other individuals providing evidence to the Committee are Dr Richard Barker, director general, Association of the British Pharmaceutical Industry (ABPI) and Dr David M Hollinshead, Royal Society of Chemistry.

The Committee's chair, Andrew Miller MP, explained the reasoning for the inquiry: "Pfizer's announcement that it will be closing its research and development facility in Kent is deeply worrying.  It is not only a cruel blow for the Pfizer employees—many are highly skilled—but it also raises questions about UK PLC's ability to use science to drive the economy."

The Parliament website has the Committee inquiry available to stream live as it happens on February 28, as well making it available to play back on video.

David Willetts MP, Minister of State for Universities and Science, is to provide evidence on Wednesday March 2.

28th February 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...

Infographics